WCM-Q Earns Global Recognition as Diabetes Center of Excellence by IDF
Weill Cornell Medicine-Qatar (WCM-Q) has achieved a major milestone by becoming the first medical institution in Qatar to be officially designated as an International... Read more.
AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA therapeutics, today announced a collaboration and license... Read more.
NATIONAL MS SOCIETY ANNOUNCES 2025 RESEARCH GRANT AWARDEES
Six UAE Research Projects Receive AED 4 Million in Grants to Drive Innovation in MS Care and Treatment The National Multiple Sclerosis Society (NMSS) has awarded... Read more.
First Response Healthcare launches innovative mobile app, aiming to provide personalised medical care at home in the UAE
The company announced the launch of their ‘Drect’ app during their annual event, reinforcing its commitment to patient-focused solutions UAE: First Response... Read more.
Dar Al Shifa Hospital Improves Productivity with Oracle Health
Dar Al Shifa Hospital in Kuwait is working to improve the efficiency of its operations with Oracle Health. By supporting its Oracle Health electronic health record... Read more.
Aster Al Raffah Walk Again Launch Advanced Robotic Rehabilitation Centre in Oman
Aster Al Raffah Hospitals & Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched the Aster Al Raffah... Read more.
KFSHRC and Cleveland Clinic Partner to Drive Innovation in Autism and Neuroscience
The agreement aims to accelerate breakthroughs in autism and neuroscience through joint expertise, project teams, and knowledge-sharing King Faisal Specialist Hospital... Read more.
Fujirebio Diagnostics’ Alzheimer’s Blood Test Cleared by FDA
New test offers a less invasive, more accessible option to detect amyloid plaques associated with Alzheimer’s In a significant development for early Alzheimer’s... Read more.
Abbott’s FreeStyle Libre® Technology Linked to Dramatic Drop in Heart-Related Hospitalizations for People with Diabetes
Real-world data shows 78% reduction in cardiovascular complications for Type 1 diabetes patients using the CGM system Last year, MedEdge MEA spotlighted Abbott’s... Read more.
GSK to Advance Innovative Liver Disease Treatment with Acquisition of Efimosfermin
GSK has announced its acquisition of efimosfermin alfa, a promising new medicine aimed at treating and preventing the progression of steatotic liver disease (SLD),... Read more.
